Figure 1From: Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis Overall survival at 60Â months for patients who underwent complete surgical cytoreduction followed by hyperthermic intraperitoneal chemotherapy (HIPEC) who were found to have unresectable disease and those who had a negative second-look surgery. Back to article page